You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN, Nov. 19, 2020 /PRNewswire/ -- The "Global Autoimmune Disorder Drug Delivery Devices Market: Focus on Product Type, Indication, Manufacturing Type, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering. The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030. Healthcare experts have found the autoimmune disorders industry to be one of the most rapidly evolving markets. The market is driven by certain factors, including the increasing global geriatric population, increasing incidence of chronic diseases including autoimmune disorders, and rise in demand for self-injectable systems. The market is favored by the development of autoimmune disorder drug delivery devices for several clinical areas such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and psoriasis. The increase in the geriatric population and incurable autoimmune disorders across the globe are expected to translate into significantly higher demand for autoimmune disorder drug delivery devices. Furthermore, the companies are investing huge amounts in research and development of autoimmune disorder drug delivery devices. The clinical trial landscape of different autoimmune disorders has been on the rise in recent years, and this will drive the autoimmune disorder drug delivery devices market in the future. Within the research report, the market is segmented based on indication, product type, manufacturing type, and region. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained. Competitive Landscape The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market. Several other companies, such as Novartis AG, F. Hoffmann- La Roche Ltd., and Bristol Myers Squibb Company, have launched drug delivery devices for autoimmune disorders. Based on region, North America holds the largest share of the autoimmune disorder drug delivery devices market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, the Asia-Pacific region is anticipated to grow at a high CAGR during the forecast period. Key Questions Answered in this Report: What are the various autoimmune disorders drug delivery devices available in the market? What are emerging drug delivery devices for the treatment of autoimmune disorders? How does the pipeline for global autoimmune disorders drug delivery devices market look like? What is the current market size and future potential of these drug delivery devices? What are the major market drivers, challenges, and opportunities in the global autoimmune disorders drug delivery devices market? What is the patent landscape of this market? What will be the impact of COVID-19 on this market? What are the guidelines implemented by different government bodies to regulate the approval of autoimmune disorders drug delivery devices? What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments? Who are the leading players holding dominating shares in the global autoimmune disorders drug delivery devices market, currently? What are the key strategies incorporated by the players of global autoimmune disorders drug delivery devices market, to sustain the competition and retain their supremacy? What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by product type), and how would it evolve in the forecast period? What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by indication), and how would it evolve in the forecast period? What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by route of administration), and how would it evolve in the forecast period? What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by usage type), and how would it evolve in the forecast period? What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by therapeutics), and how would it evolve in the forecast period? Which region is expected to contribute to the highest revenue of the global autoimmune disorders drug delivery devices market during the forecast period? Key Topics Covered: 1 Technology Definition1.1 Inclusion and Exclusion Criteria 2 Research Scope2.1 Key Questions Answered in the Report 3 Research Methodology3.1 Autoimmune Disorder Drug Delivery Devices Market: Research Methodology3.2 Primary Data Sources3.3 Secondary Data Sources3.4 Market Estimation Model3.5 Criteria for Company Profiling 4 Market Overview4.1 Historic Overview and Future Scope of Injectable Drug Delivery Devices4.2 Pre-Filled Syringes Manufacturing and Packaging Challenges4.3 Global Autoimmune Disorder Drug Delivery Devices Market and Growth Potential, 2019-20304.4 Pricing and Reimbursement Scenario4.5 Impact of Patent Expiry and Entry of Biosimilars on Autoimmune Disorder Drug Delivery Devices Market4.6 Impact of COVID-19 on Autoimmune Disorder Drug Delivery Devices Market 5 Industry Insights5.1 Overview5.2 Legal Requirements and Frameworks Across the Globe5.3 Regulatory Framework and Government Initiatives5.4 Legal Requirements and Frameworks in North America5.4.1 Food and Drug Administration (FDA)5.4.2 Health Canada5.5 Legal Requirements and Frameworks in Europe5.5.1 European Union5.6 Legal Requirements and Frameworks in Asia-Pacific5.6.1 National Medical Products Administration (NMPA)5.6.2 Pharmaceutical and Medical Device Agency (PMDA)5.6.3 Central Drug Standard Control Organization (CDSCO) 6 Patent Landscape6.1 Patent Analysis (by Drug Delivery Devices)6.2 Patent Analysis (by IPC Code)6.3 Patent Analysis (by Country)6.4 Patent Analysis (by Company) 7 Market Dynamics7.1 Overview7.2 Impact Analysis7.3 Drivers7.3.1 Increased Prevalence of Autoimmune Disorders7.3.2 Technological Advancements in the Field of Pre-Filled Syringes7.3.3 Rising Geriatric Population7.3.4 Surge of Biosimilars and Biologics in the Pharmaceutical Market7.3.5 Device Connectivity to Ease Competitive Pressure7.4 Restraints7.4.1 Strict Legal Requirements and Regulations7.4.2 Alternative Drug Delivery Technology7.5 Opportunities7.5.1 Providing Injectable Drug Delivery Devices for Untapped Autoimmune Disorders7.5.2 Opportunities for Personalizing Treatments in Autoimmune Diseases 8 Global Autoimmune Disorder Drug Delivery Devices Market, (by Indication), $Million, 2019-20308.1 Rheumatoid Arthritis8.2 Psoriasis8.3 Multiple Sclerosis8.4 Inflammatory Bowel Diseases8.5 Systemic Lupus Erythematosus 9 Global Autoimmune Disorder Drug Delivery Devices Market, (by Product), $Million, 2019-20309.1 Introduction9.2 Pen Injectors9.3 Auto-Injectors9.4 Pre-filled Syringes9.5 Vials 10 Global Autoimmune Disorder Drug Delivery Devices Market, (by Manufacturing Type), $Million, 2019-203010.1 In-House Manufacturing10.2 Outsourced Manufacturing 11 Global Autoimmune Disorder Drug Delivery Devices Market, (by Region), $Million, 2019-2030 12 Competitive Landscape12.1 Key Developments and Strategies12.1.1 Regulatory and Legal Developments12.1.2 Partnerships, Alliances, and Business Expansions12.1.3 Mergers and Acquisitions12.2 Market Share Analysis 13 Company Profiles13.1 Overview13.2 Amgen Inc.13.2.1 Company Overview13.2.2 Role of Amgen Inc. in Global Autoimmune Disorder Drug Delivery Devices Market13.2.3 Financials13.2.4 Key Insights about Financial Health of the Company13.2.5 SWOT Analysis13.3 AbbVie Inc.13.4 Bayer AG13.5 Biogen Inc.13.6 Bristol-Myers Squibb Company13.7 Eli Lilly & Company13.8 F. Hoffmann-La Roche Ltd13.9 GlaxoSmithKline plc13.10 Johnson & Johnson Services, Inc.13.11 Merck KGaA13.12 Novartis AG13.13 Sanofi S.A.13.14 Teva Pharmaceutical Industries Ltd.13.15 UCB Pharma SA. For more information about this report visit https://www.researchandmarkets.com/r/ydphaf Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

Answer: Global Autoimmune Disorder Drug Delivery Devices Market to 2030